Mark David Novara

All filings by Mark David Novara on record concern Tandem Diabetes Care Inc. We count 24 filings; the first trade dates from 15 November 2024 and the latest from 17 March 2026.

Both buying and selling appear: 1 purchase worth €12k, against 2 sales worth €3,787. Taken together, the purchases exceed the sales by €7,954. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 11 share grants and 10 option exercises. 2026 to date brings no purchases and 2 sales.

The newest entry dates from 18 March 2026: a share grant of €105k, in Tandem Diabetes Care Inc. The most recent open-market purchase was published on 19 November 2024, 720 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.